Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

AccelSafety is an all-encompassing pharmacovigilance solution crafted by Techsol Life Sciences, centered around the Oracle Argus Safety application, designed to streamline the unified gathering, medical evaluation, and regulatory reporting of safety surveillance data for both clinical and post-marketing purposes. This fully managed cloud-based platform empowers emerging biopharma companies, device manufacturers, and service providers to effectively handle safety data while ensuring their business decisions align with global compliance standards. Among its primary advantages are expedited Argus Safety implementation, migration, and validation that reduce effort by 70%; secure transfer of existing safety data to the AccelSafety Cloud; and enhanced case processing efficiency through tailored configurations and built-in automation. Additionally, users benefit from extensive operational insights provided by advanced reporting tools, line listings, and analytics packages, as well as round-the-clock support from the Argus Safety Service Desk for user inquiries, incident resolutions, and change management needs. Overall, AccelSafety stands out as a pivotal tool for organizations looking to optimize their pharmacovigilance processes and uphold regulatory obligations effectively.

Description

Sentria is a cutting-edge platform that utilizes artificial intelligence to manage adverse event cases and conduct post-marketing surveillance. This software solution is user-friendly, highly customizable, and automated, ensuring it meets industry regulations to improve the efficiency, speed, and accuracy of adverse event handling. It supports pharmacovigilance compliance with international ICH guidelines while adhering to local regulatory requirements for the assessment of adverse events. By providing an easy-to-use interface enhanced with pharmacovigilance automation, Sentria minimizes reporting errors through smart alerts and simplifies report processing by employing international coding standards such as MedDRA and ATC/WHO. The platform enhances analytical capabilities through the use of semantic artificial intelligence tailored for pharmacovigilance needs. Notably, Sentria offers features like secure access controlled by user credentials, comprehensive auditable logs to ensure compliance, and a secure encrypted cloud environment for data protection. These functionalities collectively empower organizations to manage adverse events more effectively, contributing to better patient safety outcomes.

API Access

Has API No 

API Access

Has API No 

Screenshots View All

Screenshots View All

Integrations

Oracle Argus Yes 

Integrations

Oracle Argus No 

Pricing Details

No price information available.
Free Trial No 
Free Version No 

Pricing Details

No price information available.
Free Trial No 
Free Version No 

Deployment

Web-Based Yes 
On-Premises No 
iPhone App No 
iPad App No 
Android App No 
Windows No 
Mac No 
Linux No 
Chromebook No 

Deployment

Web-Based Yes 
On-Premises No 
iPhone App No 
iPad App No 
Android App No 
Windows No 
Mac No 
Linux No 
Chromebook No 

Customer Support

Business Hours Yes 
Live Rep (24/7) Yes 
Online Support Yes 

Customer Support

Business Hours Yes 
Live Rep (24/7) No 
Online Support Yes 

Types of Training

Training Docs Yes 
Webinars No 
Live Training (Online) Yes 
In Person Yes 

Types of Training

Training Docs Yes 
Webinars No 
Live Training (Online) Yes 
In Person Yes 

Vendor Details

Company Name

Techsol Life Sciences

Founded

2010

Country

United States

Website

www.techsollifesciences.com/services/accelsafety/

Vendor Details

Company Name

dezzai

Founded

2016

Country

Spain

Website

dezzai.com/en/sentria/

Product Features

Product Features

Alternatives

Compier Literature Screening Reviews

Compier Literature Screening

Techsol Life Sciences